Cargando…

Reasons People Who Use Opioids Do Not Accept or Carry No-Cost Naloxone: Qualitative Interview Study

BACKGROUND: Many people use opioids and are at risk of overdose. Naloxone is an opioid antagonist used to counter the effects of opioid overdose. There is an increased availability of naloxone in New York City; however, many who use opioids decline no-cost naloxone even when offered. Others may have...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bennett, Alex S, Freeman, Robert, Des Jarlais, Don C, Aronson, Ian David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	JMIR Publications 2020
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7787889/ https://www.ncbi.nlm.nih.gov/pubmed/33355094 http://dx.doi.org/10.2196/22411

Ejemplares similares

Acceptability of smartphone applications for facilitating layperson naloxone administration during opioid overdoses
por: Marcu, Gabriela, et al.
Publicado: (2019)

“They’re not doing enough.”: women’s experiences with opioids and naloxone in Toronto
por: Macleod, Emilie R., et al.
Publicado: (2021)

Practical implications of naloxone knowledge among suburban people who use opioids
por: Schneider, Kristin E., et al.
Publicado: (2021)

Racial/ethnic disparities in opioid overdose prevention: comparison of the naloxone care cascade in White, Latinx, and Black people who use opioids in New York City
por: Khan, Maria R., et al.
Publicado: (2023)

Naloxone for opioid toxicity and overdose in the community
por: Jauncey, Marianne, et al.
Publicado: (2021)

Characterization of hospitalized patients who received naloxone while receiving opioids with or without gabapentinoids
por: Desai, Payal H., et al.
Publicado: (2021)

Prescription opioid misuse and its relation to injection drug use and hepatitis C virus infection: protocol for a systematic review and meta-analysis
por: Jordan, Ashly E, et al.
Publicado: (2014)

Overdose Prevention and Naloxone Prescription for Opioid Users in San Francisco
por: Enteen, Lauren, et al.
Publicado: (2010)

Naloxone protection, social support, network characteristics, and overdose experiences among a cohort of people who use illicit opioids in New York City
por: Bennett, Alex S., et al.
Publicado: (2022)

Opioid Drug Utilization and Cost Outcomes Associated With the Use of Buprenorphine-Naloxone in Patients With a History of Prescription Opioid Use
por: Kaur, Aman Deep, et al.
Publicado: (2008)

HIV treatment, antiretroviral adherence and AIDS mortality in people who inject drugs: a scoping review
por: Uusküla, Anneli, et al.
Publicado: (2023)

Naloxone Use in Novel Potent Opioid and Fentanyl Overdoses in Emergency Department Patients
por: Amaducci, Alexandra, et al.
Publicado: (2023)

Another frontier for harm reduction: contraceptive needs of females who inject drugs in Estonia, a cross-sectional study
por: Uusküla, Anneli, et al.
Publicado: (2018)

A Multistage Process Model of How a Person Who Currently Injects Drugs Comes to Assist Persons Who Do not Inject with Their First Injections
por: Des Jarlais, Don C., et al.
Publicado: (2021)

A qualitative study of persons who inject drugs but who have never helped others with first injections: how their views on helping contrast with the views of persons who have helped with first injections, and implications for interventions
por: Barnes, David M., et al.
Publicado: (2018)

Harm reduction behaviors are associated with carrying naloxone among patients on methadone treatment
por: Kozak, Zofia, et al.
Publicado: (2023)

Utilizing buprenorphine–naloxone to treat illicit and prescription-opioid dependence
por: Mauger, Sofie, et al.
Publicado: (2014)

Opioid Education and Nasal Naloxone Rescue Kits in the Emergency Department
por: Dwyer, Kristin, et al.
Publicado: (2015)

Comparison of Buprenorphine and Buprenorphine/naloxone in Detoxification of Opioid-dependent Men
por: Ziaaddini, Hassan, et al.
Publicado: (2018)

Naloxone should remain the appropriate antidote to treat opioid overdose
por: Mégarbane, Bruno, et al.
Publicado: (2020)

Naloxone interventions in opioid overdoses: a systematic review protocol
por: Shaw, Lindsay Victoria, et al.
Publicado: (2019)

Methylnaltrexone and Naloxone for Opioid-induced Constipation in the Critical Care Setting
por: Saini, Harneel S, et al.
Publicado: (2020)

Take-home Naloxone at Opioid Treatment Programs: A Lifesaver
por: Katzman, Joanna G., et al.
Publicado: (2022)

Treatment of Opioid Withdrawal Syndrome Triggered by Oxycodone/Naloxone with Dexmedetomidine
por: Go, Se-Il, et al.
Publicado: (2023)

Impact of California Statute on Naloxone Availability and Opioid Overdose Rates
por: Gallant, Tara L., et al.
Publicado: (2023)

Association of Naloxone Coprescription Laws With Naloxone Prescription Dispensing in the United States
por: Sohn, Minji, et al.
Publicado: (2019)

Modeling HIV transmission among persons who inject drugs (PWID) at the “End of the HIV Epidemic” and during the COVID-19 pandemic
por: Jarlais, Don Des, et al.
Publicado: (2022)

The policy landscape for naloxone distribution in four states highly impacted by fatal opioid overdoses
por: Bohler, Robert M., et al.
Publicado: (2022)

Overdose education and naloxone distribution program design informed by people who use drugs and naloxone distributors
por: Enich, Michael, et al.
Publicado: (2023)

Association of Take-Home Naloxone and Opioid Overdose Reversals Performed by Patients in an Opioid Treatment Program
por: Katzman, Joanna G., et al.
Publicado: (2020)

Preventing deaths from rising opioid overdose in the US – the promise of naloxone antidote in community-based naloxone take-home programs
por: Straus, Michele M, et al.
Publicado: (2013)

Higher naloxone dosing in a quantitative systems pharmacology model that predicts naloxone-fentanyl competition at the opioid mu receptor level
por: Moss, Ronald B., et al.
Publicado: (2020)

Harm reduction in the USA: the research perspective and an archive to David Purchase
por: Des Jarlais, Don C.
Publicado: (2017)

New developments in the management of opioid dependence: focus on sublingual buprenorphine–naloxone
por: Soyka, Michael
Publicado: (2015)

Naloxone urban legends and the opioid crisis: what is the role of public health?
por: Crabtree, Alexis, et al.
Publicado: (2019)

Intention to get naloxone among patients prescribed opioids for chronic pain
por: Huang, Yinan, et al.
Publicado: (2022)

Who is using take-home naloxone? An examination of supersavers
por: Eide, Desiree, et al.
Publicado: (2022)

Correction: Higher naloxone dosing in a quantitative systems pharmacology model that predicts naloxone-fentanyl competition at the opioid mu receptor level
Publicado: (2020)

Non-fatal drug overdose among persons who inject drugs during first two years of the COVID-19 pandemic in New York City: Prevalence, risk factors
por: Jarlais, Don Des, et al.
Publicado: (2023)

Using standardized methods for research on HIV and injecting drug use in developing/transitional countries: case study from the WHO Drug Injection Study Phase II
por: Des Jarlais, Don C, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_7rcjb9k0bb130tqubg8het7io4